Novel biomaterial prevents rejection of transplants for type 1 diabetes: Clinical trial is planned based on results from preclinical study.
In type 1 diabetes, an autoimmune response attacks the pancreas’s insulin-producing beta cells, leading to marked fluctuations in blood sugar levels. Lifelong daily insulin treatments are standard for patients, but replacing lost beta cells through transplants of islets, a group of cells in the pancreas, represents an attractive option. This strategy requires that patients take […]